Advertisement

Rheumatology International

, 29:1463 | Cite as

Systemic lupus erythematosus in Egyptian children

  • Samia Salah
  • Hala Mohamed Lotfy
  • Samar M. Sabry
  • Azza El Hamshary
  • Heba Taher
Original Article

Abstract

The aim of the study was to study the characteristics of systemic lupus erythematosus (SLE) in the Egyptian population, comparing it to other populations. We retrospectively studied 207 patients with SLE diagnosed between 1990 and 2005. We obtained clinical features and laboratory data and analyzed them statistically. We studied 151 female and 56 male SLE patients. The female to male ratio was 2.7 to 1 and the mean age at presentation was 10 ± 2.7 years (range 2–16). The mean disease duration was 6.47 ± 3.74 years. At diagnosis, musculoskeletal, constitutional and mucocutaneous manifestations were the commonest features. During follow-up, the prevalence of nephritis (67%), hematological manifestations (44.9%), photosensitivity (44%), arthritis (39%), malar rash (38.2%), serositis (32.9%) and neuropsychiatric manifestations (24.25%) increased significantly. Those whose age of onset of the disease was ≤5 years (nine patients) had significantly more common hematological affection (P value = 0.0005). The characteristics of SLE in Egyptian patients show some similarities to other series of Middle Eastern countries, but with a lower female to male ratio. Disease onset below 5 years is extremely rare (4.35%), commonly presenting with hematological manifestations. The kidney was the commonest major internal organ involved, and also an important cause of death.

Keywords

Systemic lupus erythematosus Lupus epidemiology Egyptian children 

Notes

Acknowledgments

We extens our special thanks to all the members of the Rheumatology Clinic, who helped us in our work, and to all the children, who participated in conducting the study.

Conflict of interest statement

None.

References

  1. 1.
    Uthman I, Nasr F, Kassak K, Masri A (1999) Systemic lupus erythematosus in Lebanon. Lupus 8:713–715. doi: 10.1191/096120399678841016 PubMedCrossRefGoogle Scholar
  2. 2.
    Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53:675–680. doi: 10.1136/ard.53.10.675 PubMedCrossRefGoogle Scholar
  3. 3.
    Thumboo J, Fong KY, Chng HH et al (1998) The effects of ethnicity on disease patterns in 472 Orientals with systemic lupus erythematosus. J Rheumatol 25:1299–1304PubMedGoogle Scholar
  4. 4.
    Alarcon GS, Friedman AW, Stratoon KV et al (1999) Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMIN cohort. Lupus 8:197–209. doi: 10.1191/096120399678847704 PubMedCrossRefGoogle Scholar
  5. 5.
    Houman MH, Smiti-Khanfir M, Ghorbell IB, Miled M (2004) Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients. Lupus 13:204–211. doi: 10.1191/0961203303lu530xx PubMedCrossRefGoogle Scholar
  6. 6.
    El-Garf A, Salah S (1990) Juvenile systemic lupus erythematosus among Egyptian children. J Rheumatol 17:1168–1170PubMedGoogle Scholar
  7. 7.
    Bahabri S, Sabban EA, Al Rashed A et al (1997) Juvenile systemic lupus erythematosus in 60 Saudi children. Ann Saudi Med 17:612–615PubMedGoogle Scholar
  8. 8.
    Al Saied K, Kamal H, Haider MZ et al (2004) Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings. Lupus 13:613–617. doi: 10.1191/0961203304lu1075xx CrossRefGoogle Scholar
  9. 9.
    Tan EM, Fries JF, Masi AT et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277. doi: 10.1002/art.1780251101 PubMedCrossRefGoogle Scholar
  10. 10.
    ACR Ad Hoc Committee on Neuropsychatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608. doi: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F Review.PMID: 10211873CrossRefGoogle Scholar
  11. 11.
    Churg J, Sobin DH (1982) Renal disease: classification and atlas of glomerular diseases. Igaku-Shoin, Tokyo, pp 127–149Google Scholar
  12. 12.
    Manzi S (2001) Epidemiology of systemic lupus erythematosus. Am J Manag Care 7:S474–S479PubMedGoogle Scholar
  13. 13.
    Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16:847–858. doi: 10.1053/berh.2002.0259 PubMedCrossRefGoogle Scholar
  14. 14.
    Vilar MJ, Sato EI (2002) Estimating the incidence of systemic lupus: erythematosus in a tropical region (Natal, Brazil). Lupus 11:528. doi: 10.1191/0961203302lu244xx PubMedCrossRefGoogle Scholar
  15. 15.
    Deligny C, Thomas L, Dubreuil F et al (2002) Systemic lupus erythematosus in Martinique: an epidemiologic study. Rev Med Interne 23(1):21–29PubMedCrossRefGoogle Scholar
  16. 16.
    Al-Jarallah K, Al-Awadi A, Siddiqui H et al (1998) Systemic lupus erythematosus in Kuwait: hospital based study. Lupus 7:434–438. doi: 10.1191/096120398678920389 PubMedCrossRefGoogle Scholar
  17. 17.
    Al-Attia HM (1996) Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J 72:677–699. doi: 10.1136/pgmj.72.853.677 PubMedCrossRefGoogle Scholar
  18. 18.
    Ali US, Dalvi RB, Merchant RH et al (1989) Systemic lupus erythematosus in Indian children. Indian Pediatr 26:868–873PubMedGoogle Scholar
  19. 19.
    Faller G, Thomson PD, Kala UK, Hahn D (2005) Demographics and presenting clinical features of childhood systemic lupus erythematosus. S Afr Med J 95:424–427PubMedGoogle Scholar
  20. 20.
    Uziel Y, Brik R, Padeh S, Mukamel M, Gorodnitski N (2007) Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus 16:142–146. doi: 10.1177/0961203306075385 PubMedCrossRefGoogle Scholar
  21. 21.
    Bakr A (2005) Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol 20:1081–1086. doi: 10.1007/s00467-005-1900-2 PubMedCrossRefGoogle Scholar
  22. 22.
    Balkaran BN, Roberts LA, Ramcharan J (2004) Systemic lupus erythematosus in Trinidadian children. Ann Trop Paediatr 24:241–244. doi: 10.1179/027249304225018984 PubMedCrossRefGoogle Scholar
  23. 23.
    Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V et al (2005) Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients. J Med Assoc Thai 88:S232–S241PubMedGoogle Scholar
  24. 24.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W (1999) The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. J Med Assoc Thai 82(Suppl 1):S104–S110PubMedGoogle Scholar
  25. 25.
    Alballa SR (1995) Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 14:342–436. doi: 10.1007/BF02208351 PubMedCrossRefGoogle Scholar
  26. 26.
    Von Scheven E, Glidden DV, Elder ME (2002) Anti-beta2-glycoprotien 1 antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 47(4):414–420. doi: 10.1002/art.10510 CrossRefGoogle Scholar
  27. 27.
    Levy DM, Massicotte MP, Harvey E et al (2003) Thromboembolism in pediatric lupus patients. Lupus 12(10):741–746. doi: 10.1191/0961203303lu458oa PubMedCrossRefGoogle Scholar
  28. 28.
    Susanne M, Earl D (2007) Systemic lupus erythematosus. Rheum Dis Clin North Am 33:471–498. doi: 10.1016/j.rdc.2007.07.008 CrossRefGoogle Scholar
  29. 29.
    Bogdanvic R, Nikolic V, Pasic S et al (2004) Lupus nephritis in childhood: a review of 53 patients followed in a single center. Pediatr Nephrol 19:36–44. doi: 10.1007/s00467-003-1278-y CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Samia Salah
    • 1
  • Hala Mohamed Lotfy
    • 1
  • Samar M. Sabry
    • 1
  • Azza El Hamshary
    • 1
  • Heba Taher
    • 1
  1. 1.Cairo University HospitalCairoEgypt

Personalised recommendations